drugset / Trial / NCT01721408
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a comparative study of the efficacy and safety of tigecycline to imipenem/cilastatin in hospitalized patients with a complicated intra-abdominal infection.
Timeline
- Start
- 2012-11
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cilastatin | Small molecule | 500 mg | Intravenous |
| Comparator | IMIPENEM ANHYDROUS | Small molecule | 500 mg | Intravenous |
| Subject | Tigecycline | Small molecule | 50 mg | Intravenous |